Ajuts a la recerca

Grants - Alzheimer’s Drug Discovery Foundation (ADDF)

Organisme

 Academic Grants and Biotechnology Grants.
 

Academic Grants: The ADDF Academic Drug Discovery and Development Program seeks to create and support innovative translational research programs for Alzheimer’s disease, related dementias and cognitive aging in academic medical centers and universities. Biomarker development studies and innovative proof of concept pilot clinical trials of new approaches to treatment, prevention and early detection are also supported.

Biotechnology Grants. ADDF helps to create new biotechnology companies, and to fund early stage biotechnology companies, with programs dedicated to Alzheimer’s disease drug discovery. Funding is provided through program-related investments (PRIs) that require return on investment based upon scientific and/or business milestones. When these milestones are met, funds return to the ADDF to increase our ability to support more research. Terms of PRIs may vary

Termini oficial

The ADDF accepts LOIs for the “General Request for Proposals” research award programs throughout the year. 2013 deadlines for full proposals are January 22, March 5, June 5, September 5, and December 5

Termini IISPV

Cal comunicar abans del 15 de abril de 2013 que es vol participar a la convocatòria, enviant un e-mail a convocatories@iispv.cat. Termini: 17 de maig de 2013

Pujar